414 related articles for article (PubMed ID: 11756711)
1. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
Youk JH; Kim CS; Lee JM
J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
[TBL] [Abstract][Full Text] [Related]
3. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
4. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
[TBL] [Abstract][Full Text] [Related]
5. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
7. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US.
Kim TK; Choi BI; Han JK; Hong HS; Park SH; Moon SG
Radiology; 2000 Aug; 216(2):411-7. PubMed ID: 10924562
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
9. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
10. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience.
Harvey CJ; Blomley MJ; Eckersley RJ; Cosgrove DO; Patel N; Heckemann RA; Butler-Barnes J
Radiology; 2000 Sep; 216(3):903-8. PubMed ID: 10966730
[TBL] [Abstract][Full Text] [Related]
11. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience.
Blomley MJ; Sidhu PS; Cosgrove DO; Albrecht T; Harvey CJ; Heckemann RA; Butler-Barnes J; Eckersley RJ; Basilico R
Radiology; 2001 Sep; 220(3):661-7. PubMed ID: 11526264
[TBL] [Abstract][Full Text] [Related]
12. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT.
Nino-Murcia M; Olcott EW; Jeffrey RB; Lamm RL; Beaulieu CF; Jain KA
Radiology; 2000 Jun; 215(3):746-51. PubMed ID: 10831693
[TBL] [Abstract][Full Text] [Related]
13. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
14. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
[TBL] [Abstract][Full Text] [Related]
15. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
[TBL] [Abstract][Full Text] [Related]
16. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K
Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903
[TBL] [Abstract][Full Text] [Related]
19. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
[TBL] [Abstract][Full Text] [Related]
20. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
